Cloning of CYP2J2 gene and identification of functional polymorphisms

Molecular Pharmacology

Volumn 61, Issue 4, 2002, Pages 840-852

  King, Lorraine M ^a   Jixiang, Ma ^a   Srettabunjong, Supawon ^a   Graves, Joan ^b   Alyce Bradbury, J ^b   Li, Leping ^b   Spiecker, Martin ^a   Liao, James K ^a   Mohrenweiser, Harvey ^c   Zeldin, Darryl C ^d  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ARACHIDONIC ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; COMPLEMENTARY DNA; CYTOCHROME P450; DNA; ICOSANOID; ISOLEUCINE; LINOLEIC ACID; RECOMBINANT PROTEIN; THREONINE; TYROSINE;

ANIMAL CELL; ARTICLE; CATALYSIS; GENE; GENE SEQUENCE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOREACTIVITY; LEPIDOPTERA; METABOLISM; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS;

ALLELES; ARACHIDONIC ACID; CLONING, MOLECULAR; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; EXONS; GENE EXPRESSION; GENOME, HUMAN; HUMANS; INTRONS; LINOLEIC ACID; MOLECULAR SEQUENCE DATA; OXYGENASES; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 18344377326     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.4.840     Document Type: Article

References (61)

1. Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus
2. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors
3. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone
4. Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonate mono-oxygenase
5. Endogenous biosynthesis of arachidonic acid epoxides in humans: Increased formation in pregnancy-induced hypertension
6. The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase
7. Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids
8. Mutational analysis of the human DNA polymerase alpha. The most conserved region in alpha-like DNA polymerases is involved in metal-specific catalysis
9. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
10. Cytochrome P450 2C is an EDHF synthase in coronary arteries
11. Localization, sequence analysis, and ethnic distribution of a 96-bp insertion in the promoter of the human CYP2E1 gene
12. Cardiovascular effects of leukotoxin (9,10-epoxy-12-octadecenoate) and free fatty acids in dogs
13. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences
14. Structural determinants of progesterone hydroxylation by cytochrome P450 2B5: The role of nonsubstrate recognition site residues
15. CYP1A1 polymorphisms and lung cancer risk: A meta-analysis
16. Complete cDNA sequence and cDNA-directed expression of CYP4A11, a fatty acid omega-hydroxylase expressed in human kidney
17. Genetic variability in susceptibility and response to toxicants
18. Site-directed mutagenesis of mouse steroid 7 alpha-hydroxylase (cytochrome P-450(7) alpha): Role of residue-209 in determining steroid-cytochrome P-450 interaction
19. Laboratory evolution of peroxide-mediated cytochrome P450 hydroxylation
20. Promoter-specific activation of RNA polymerase-Ii Transcription by Sp1
21. Cytochrome P450 1B1 gene mutations in Japanese patients with primary congenital glaucoma(1)
22. A novel species of cytochrome P-450 (P-450ib) specific for the small intestine of rabbits. cDNA cloning and its expression in COS cells
23. Leukotoxin, a linoleate epoxide: Its implication in the late death of patients with extensive burns
24. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease
25. Application of snp technologies in medicine: Lessons learned and future challenges
26. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4
27. Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney
28. Mapping of the CYP2J cytochrome P450 genes to human chromosome 1 and mouse chromosome 4
29. The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: A case-control study and meta-analysis
30. Cytochrome P-450 metabolism of arachidonic acid
31. Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase
32. Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s
33. Polymorphism of human CYP2D genes involved in drug metabolism: Possible relationship to individual cancer risk
34. Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer
35. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
36. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing
37. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
38. Activation of Gas mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatriencic acids
39. Identification, functional characterization, and regulation of a new cytochrome P450 subfamily, the CYP2Ns
40. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation
41. The carbon monoxide-binding pigment of liver microsomes I. Evidence for its hemoprotein nature
42. Existence of leukotoxin 9,10-epoxy-12-octadecenoate in lung lavages from rats breathing pure oxygen and from patients with the adult respiratory distress syndrome
43. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer
44. Genetic susceptibility to adverse drug reactions
45. Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominately expressed in brain
46. Recent advances in molecular genetics of glaucomas
47. P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues
48. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
49. Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer
50. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes
51. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart
52. 2+ channels and contraction in mammalian heart cells
53. Overexpression of cytochrome P450 CYP2J2 protects against hypoxia-reoxygenation injury in cultured bovine aortic endothelial cells
54. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform
55. Predominant expression of an arachidonate epoxygenase in islets of Langerhans cells in human and rat pancreas
56. CYP2J subfamily cytochrome P450s in the gastrointestinal tract: Expression, localization, and potential functional significance
57. CYP2J subfamily P450s in the lung: Expression, localization, and potential functional significance
58. Regio- and enantiofacial selectivity of epoxyeicosatrienoic acid hydration by cytosolic epoxide hydrolase
59. Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway
60. cDNA cloning, heterologous expression, and characterization of rat intestinal CYP2J4